SBMF Pathology Services Partners with Agilent to Launch Digital Pathology, Driving Precision Medicine and AI Innovation.
SBMF Pathology Services today announced the implementation of its digital pathology platform in collaboration with Agilent Technologies, marking a major milestone in the organization’s 113-year legacy of innovation. With this advancement, SBMF joins the top 10% of pathology labs nationwide utilizing digital technology for primary diagnosis, positioning itself at the forefront of precision medicine, AI-driven diagnostics, and digital transformation in healthcare.
SBMF’s adoption of industry-leading digital technology enhances diagnostic workflows, accelerates turnaround times, and enables global collaboration on complex cases.
Transforming Diagnosis with Digital Pathology
SBMF selected Agilent Technologies as its partner for this transformation, leveraging Agilent’s end-to-end digital pathology expertise and proven track record in delivering scalable, interoperable solutions. The digital platform, Proscia’s Concentriq®, is trusted by pharmaceutical and research organizations worldwide, to provide pathologists with an intuitive, streamlined experience for interpreting and managing cases.
Each whole-slide image contains over 1 billion pixels, delivering unparalleled detail and enabling the creation of a direct, data-rich profile of disease. This wealth of information is essential for advancing precision medicine, allowing for more personalized and effective treatments. SBMF’s adoption of this platform also positions the organization to contribute to AI-driven research, helping to develop tools that better identify and treat diseases.
“Digital pathology is more than a technological upgrade—it’s how we bring the future of diagnostics home to the patients and providers we serve. By embracing this innovation, SBMF is redefining accuracy and speed, fostering collaboration, and ensuring our community benefits from faster and reliable care.” – Tim Stolt, COO, SBMF
Addressing a Critical Workforce Challenge
The pathology field faces an urgent supply-demand imbalance:
•Between 2007 and 2017, the U.S. pathologist population declined by 17.5%.
•During the same period, pathologists’ workload surged by 41.73%.
•A 2022 analysis revealed that only 65% of U.S.-based practices could fill all open positions.
•The American Cancer Society estimates over 2 million new cancer cases will be diagnosed in the U.S. in 2026.
As cancer diagnoses rise and biopsy volumes increase, SBMF’s digital transformation ensures its skilled pathologists are equipped with the latest technology to meet these challenges head-on. SBMF’s investment in digital technology delivers the important diagnostic tools required to attract physician talent to our community.
A Commitment to Community and Innovation
SBMF believes in the power of the community laboratory and its value to local providers. By placing advanced digital tools in the hands of expert pathologists and scientists, SBMF enhances its ability to deliver accurate, timely diagnoses, reducing time to treatment and improving patient outcomes.
For 113 years, SBMF’s mission has remained steadfast: to provide high-quality pathology and blood services to the communities we serve, always remembering that there is a life behind everything we do.
“We are excited for the opportunity to collaborate in this cutting-edge healthcare space. SBMF has consistently led the way in numerous advancements, and we are confident that implementing these services will be transformative in delivering the next level of high-tech care that patients rightfully deserve. This collaboration promises to usher in a new era of innovative solutions, ensuring that our patients benefit from the most advanced and effective treatments available.”– Tim Travis, CEO SBMF
About SBMF SBMF Pathology Services, located in South Bend, IN, has been a trusted leader in pathology and blood services for over a century. Serving healthcare providers and patients across the region, SBMF combines deep clinical expertise with cutting-edge technology to deliver accurate, timely diagnoses that improve patient outcomes. Learn more at https://www.sbmf.org/.
Media Contact:
Dominic Carpenter
Vice President of Marketing and Business Development
South Bend Medical Foundation
574-204-4483
dcarpenter@sbmf.org